Eliem Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Eliem Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Eliem Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eliem Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.6M | 1.3M | 2.01 |
| 2025-06-30 | $1.7M | 1.3M | 1.24 |
| 2025-03-31 | $1.8M | 1.5M | 1.22 |
| 2024-12-31 | $2.7M | 1.5M | 1.80 |
| 2024-09-30 | $7.8M | 1.5M | 5.09 |
| 2024-06-30 | $2.3M | 326k | 7.11 |
| 2024-03-31 | $851k | 311k | 2.74 |
| 2023-12-31 | $838k | 311k | 2.70 |
| 2023-09-30 | $815k | 310k | 2.63 |
| 2023-06-30 | $769k | 275k | 2.80 |
| 2023-03-31 | $796k | 275k | 2.90 |
| 2022-12-31 | $1.0M | 275k | 3.67 |
| 2022-06-30 | $829k | 274k | 3.02 |
| 2022-03-31 | $2.6M | 305k | 8.39 |
| 2021-09-30 | $3.6M | 200k | 17.98 |